WuXi STA
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA)
Articles
Integrated Pre-Formulation Studies for Fast Advancement of Drug Candidates to Human Clinical Studies
April 15th 2020Looking for a fast pathway to an investigational new drug application (IND) for your new drug candidates? This webcast will discuss strategies to select the most developable molecules and quickly develop an IND-ready formulation within 8–12 weeks using real-world case studies. Live: Wednesday, April 15, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST On demand available after airing until Apr. 15, 2021 Register free
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 22nd 2024 | Updated: November 27th 2024
Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice
Published: November 22nd 2024 | Updated: November 27th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
Published: October 28th 2024 | Updated: November 27th 2024
Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development
Published: November 6th 2024 | Updated: November 27th 2024
Automate Aseptic Filling: Closing the System at Full Modularity
